Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Get ready folks - LBL
View:
Post by gainwidpatience on Apr 23, 2020 11:57pm

Get ready folks - LBL

https://www.afr.com/companies/healthcare-and-fitness/mesoblast-s-covid-19-treatment-shows-positive-signs-20200424-p54muq?&utm_source=twitter&utm_medium=social&utm_campaign=nc&eid=socialn:twi-14omn0055-optim-nnn:nonpaid-27/06/2014-social_traffic-all-organicpost-nnn-afr-o&campaign_code=nocode&promote_channel=social_twitter

 

Listed biotech company Mesoblast says it is seeing positive signs for the use of its stem cell therapy in treating critically ill COVID-19 patients.

The company said 83 per cent of ventilator-dependent patients with a high risk of mortality who received its stem cell treatment have survived during early compassionate usage in New York's Mount Sinai hospital.

Comment by MaterialWorld on Apr 24, 2020 6:54am
Great post gainwidpatience. Like I posted before, it's not if for LBL, it's when. I say very soon. Guy is sure holding his cards close to his chest. Not letting the cat outa the bag so to speak. Not even a leaked press release by members of his staff. They must have all signed nondisclosure agreements because that info would be worth millions and millions of dollars. Properly harvested ...more  
Comment by Unicorn9000 on Apr 24, 2020 7:21am
Stop stealing and using other company's news. scary stuff 
Comment by Torontonine on Apr 24, 2020 8:59am
It's called research. Have a great day 9000
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities